Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
CorMedix Inc.
CRMD · SEC Filings
website
191
CorMedix Inc. is a biopharmaceutical company engaged in the development and commercialization of med...
Price
5.47
Market Cap
426.36 M
Float
77.36 M
Country
US
Sector
Healthcare
Exchange
NASDAQ
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about CRMD
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
CorMedix Inc.
CRMD · SEC Filings
77.36 M
Float
5.47
Price
426.36 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 5, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 7, 2025
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 6, 2025
News
TYPE
HEADLINE
FILED AT
8-K
NEW
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics for Expansion in Institutional Care
Nov 9, 2026
8-K
CorMedix Provides Business Update, Reaffirms 2026 Total Revenue Guidance, and Reports Third Quarter Cash Position
Nov 2, 2026
8-K
CorMedix Announces FDA Acceptance for Priority Review of Supplemental NDA for REZZAYO® for Prophylaxis of Invasive Fungal Diseases
Oct 19, 2026
8-K
CorMedix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13, 2026
8-K
Notice of Proposed Settlement in CorMedix Inc. Derivative Litigation
Aug 7, 2026
8-K
CorMedix Inc. Announces Executive Leadership Changes
Jul 2, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B5
REGISTERED OFFERING
Jun 30, 2025
424B5
PENDING OFFERING
Jun 26, 2025
424B5
SHELF OFFERING | Shares amount: 7,500,000 | Share price: $4.00 | Warrants amount: 2,500,625 | Offering amount: $39,999,999.00
Jun 30, 2023
424B5
SHELF PENDING OFFERING | PENDING OFFERING | Share price: $4.97
Jun 28, 2023
424B5
ATM | Offering amount: $50,000,000
Aug 12, 2021
424B5
Common Stock-
Feb 5, 2021
Registrations
TYPE
HEADLINE
FILED AT
S-8 POS
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jun 25, 2026
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 13, 2025
S-3ASR
October 2025 SHELF | Shares amount: 6,323,833
Oct 7, 2025
RW
Form RW - Registration Withdrawal Request
Oct 7, 2025
S-3ASR
October 2025 SHELF | Shares amount: 6,323,833
Oct 3, 2025
RW
Form RW - Registration Withdrawal Request
Oct 3, 2025
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
NEW
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Nov 9, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 29, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Apr 29, 2026
PRE 14A
Form PRE 14A - Other preliminary proxy statements
Apr 17, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 24, 2025
PRER14A
Form PRER14A - Preliminary Proxy Soliciting materials
Oct 14, 2025
Ownerships
TYPE
HEADLINE
FILED AT
4
Dillione Janet (Reporting)
Sep 18, 2026
4
Blum Susan (Reporting)
Sep 1, 2026
4
Hurlburt Elizabeth (Reporting)
Sep 1, 2026
4
Zelnick Kaufman Beth (Reporting)
Sep 1, 2026
SCHEDULE 13G/A
SHAIBATALHAMD AYMEN ABDALKADER (Filed by)
Jun 12, 2026
SCHEDULE 13G/A
SHAIBATALHAMD AYMEN ABDALKADER (Filed by)
Jun 12, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
